Favipiravir Bioanalysis [Regulatives / Guidelines]

posted by Ayman Rabayah – Jordan, 2020-08-11 10:44 (1375 d 22:23 ago) – Posting: # 21854
Views: 1,859

Hellow colleagues
Need your feedback about the Bio-analysis of Favipiravir, do the metabolite (Favipiravir RTP) need to be measured or only the Favipiravir, since no FDA or EMEA related guidance issued till date.
Appreciate your thoughts.

Ayman Ahmad

Complete thread:

UA Flag
Activity
 Admin contact
23,029 posts in 4,834 threads, 1,641 registered users;
37 visitors (0 registered, 37 guests [including 8 identified bots]).
Forum time: 09:08 CEST (Europe/Vienna)

The most erroneous stories are those we think we know best–
and therefore never scrutinize or question.    Stephen Jay Gould

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5